Rentschler and Leukocare announce strategic alliance and equity investment
Laupheim and Munich/Martinsried, Germany, February 2, 2017 – Rentschler Biotechnologie GmbH, Laupheim and Leukocare AG, Martinsried today announced a strategic alliance under which Leukocare will become the specialized technology partner and the exclusive formulation developer for Rentschler’s biopharmaceuticals business. Rentschler in return will become the first and only contract development and manufacturing organization (CDMO) to … Skaityti toliau